Free Trial

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

Ionis Pharmaceuticals logo
$60.52 -1.22 (-1.98%)
As of 03:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Ionis Pharmaceuticals SEC Filings

DateFilerForm TypeView
09/16/2025
3:56 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
4:04 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
4:05 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2025
5:30 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2025
5:30 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:34 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:34 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:36 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:37 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:37 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:38 PM
Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:38 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:38 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:40 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:41 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:28 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:28 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:29 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025
7:29 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
5:29 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
5:30 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
5:30 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
5:37 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
5:26 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2025
4:31 PM
Ionis Pharmaceuticals (Subject)
LOSCALZO JOSEPH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
4:15 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
3:54 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
3:37 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025
3:30 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
7:31 PM
Ionis Pharmaceuticals (Subject)
WENDER JOSEPH H (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
4:34 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
3:42 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
3:13 PM
Ionis Pharmaceuticals (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
6:05 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2025
12:03 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025
4:23 PM
Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2025
1:01 PM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2025
5:14 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
9:34 AM
Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
08/08/2025
5:55 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
5:44 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
4:28 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2025
3:53 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2025
2:56 PM
Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2025
10:16 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
3:54 PM
HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:54 PM
Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:54 PM
Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:54 PM
Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2025
3:59 PM
Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
7:54 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
8:00 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
5:02 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
6:18 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
3:26 PM
Ionis Pharmaceuticals (Filer)
Form DEFA14A
04/25/2025
3:27 PM
Ionis Pharmaceuticals (Filer)
Form ARS
04/17/2025
3:53 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:53 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:53 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Ionis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/16/2025
4:38 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2025
4:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2025
4:41 PM
Ionis Pharmaceuticals (Subject)
Jenne Kyle (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:45 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:16 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:17 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:06 PM
Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
10:15 AM
Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:53 PM
Capital World Investors (Filed by)
Ionis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/07/2025
10:55 AM
Ionis Pharmaceuticals (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
02/06/2025
5:26 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
5:27 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:26 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM
Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM
Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM
Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:43 PM
Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:41 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:01 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:02 PM
Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:03 PM
Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:58 PM
Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:59 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:40 PM
Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM
Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM
Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IONS) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners